Evidence map›Paper›PMID 39859817›Full record

ArticleMaterials (Basel, Switzerland)2025

Modification of Ti13Nb13Zr Alloy Surface via Plasma Electrolytic Oxidation and Silver Nanoparticles Decorating.

Przemysław Gołasz, Agnieszka Płoska, Viktoriia Korniienko, Kateryna Diedkova, Yuliia Varava, Rafał Zieliński, Maksym Pogorielov, Wojciech Simka

Abstract read
In one paragraph

Article in Materials (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Przemysław GołaszDepartment of Inorganic Chemistry, Analytical Chemistry, and Electrochemistry, Faculty of Chemistry, Silesian University of Technology, 44-100 Gliwice, Poland.
Agnieszka PłoskaDepartment of Inorganic Chemistry, Analytical Chemistry, and Electrochemistry, Faculty of Chemistry, Silesian University of Technology, 44-100 Gliwice, Poland.
Viktoriia KorniienkoInstitute of Atomic Physics and Spectroscopy, University of Latvia, Jelgavas iela 3, LV-1004 Riga, Latvia.
Kateryna DiedkovaInstitute of Atomic Physics and Spectroscopy, University of Latvia, Jelgavas iela 3, LV-1004 Riga, Latvia.
Yuliia VaravaBiomedical Research Centre, Sumy State University, R-Korsakova Street, 40007 Sumy, Ukraine.ORCID 0000-0002-1007-3743
Rafał ZielińskiStomatologia na Księżym Młynie, 90-365 Łodz, Poland.ORCID 0000-0002-9897-5003
Maksym PogorielovDepartment of Inorganic Chemistry, Analytical Chemistry, and Electrochemistry, Faculty of Chemistry, Silesian University of Technology, 44-100 Gliwice, Poland.ORCID 0000-0001-9372-7791
Wojciech SimkaDepartment of Inorganic Chemistry, Analytical Chemistry, and Electrochemistry, Faculty of Chemistry, Silesian University of Technology, 44-100 Gliwice, Poland.ORCID 0000-0002-2648-5523

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The dynamically developing field of implantology requires researchers to search for new materials and solutions. In this study, TiNbZr samples were investigated as an alternative for popular, but potentially hazardous TiAl6V4. Samples were etched, sandblasted, subjected to PEO, and covered in AgNP suspension. Simultaneously, SEM images were taken, and the wettability and roughness of the surface were measured. Samples covered in AgNPs were subjected to biological trials. A six-day measurement of human fibroblast proliferation was conducted to assess biocompatibility, and the population of

Indexed as

implantsilver nanoparticlessurface treatmenttitanium alloy

Identifiers

PMID39859817
PMCPMC11767042

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.